Who Paid My Doc
Jack Wang
Neurocritical Care Stanford, CA Medical Doctor
NPI 1154733053 CMS profile 7455975
300 Pasteur Dr, Stanford, CA 94305
General payments
$2,500
Research payments
$0
Ownership & investment interest
$0
Through program year 2024, Jack Wang of Stanford, CA is reported in the CMS Open Payments database as having received $2,500 across 1 general payment and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 86th percentile of Neurocritical Care profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2024 | General | $2,500 | 1 |
Beside peers
- Jack Wang
- Neurocritical Care median
- Middle half of Neurocritical Care
- National median
In program year 2025, general payments to Jack Wang were reported at $0. Among 223 Neurocritical Care profiles paid that year, the median was $98 and the middle half received between $34 and $262.
Show as a table
| Year | Jack Wang | Neurocritical Care median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $125 | $47–$286 | $163 |
| 2020 | $0 | $74 | $21–$153 | $114 |
| 2021 | $0 | $108 | $34–$250 | $132 |
| 2022 | $0 | $115 | $31–$277 | $149 |
| 2023 | $0 | $127 | $35–$275 | $160 |
| 2024 | $2,500 | $127 | $44–$265 | $164 |
| 2025 | $0 | $98 | $34–$262 | $169 |
Breakdown
Billing to Medicare
Part B · data year 2024 · 2 billing codesPaid by Medicare
$21,489
Medicare patients
46
Services billed
117
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Atrial fibrillation | 57% | |
| Chronic kidney disease | 57% | |
| Ischemic heart disease | 52% | |
| Alzheimer's or dementia | 46% | |
| Heart failure | 43% | |
| Diabetes | 41% | |
| Arthritis | 35% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
1 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Neurocritical Care in California
Nerses Sanossian
Neurocritical Care · Los Angeles, CA
May Kim-Tenser
Neurocritical Care · Los Angeles, CA
Wengui Yu
Neurocritical Care · Orange, CA
Marion Buckwalter
Neurocritical Care · Stanford, CA
Johannes Pulst-Korenberg
Neurocritical Care · Los Angeles, CA
Arash Afshinnik
Neurocritical Care · Fresno, CA
Related records
Neurocritical Care in California
Practitioners in the same specialty and state, ranked by reported value.
All Neurocritical Care
Everyone recorded under this specialty, nationwide.
Doctors in California
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.